Drugs

The Alliance for Regenerative Medicine Holds Third Annual Stem Cell Meeting on the Mesa Regen Med Partnering Forum

WASHINGTON, DC: Meeting Will Take Place October 14 and 15 in La Jolla, California ...

Selway Capital Acquisition Corporation Announces Extension of Tender Offer for Series B Shares

NEW YORK, NY: ...

Acura Pharmaceuticals to Develop Improved NEXAFED(R)

PALATINE, IL: IMPEDE(R) 2.0 Reduces One-Pot Methamphetamine Yield to Near Zero ...

Theravance to Report Second Quarter 2013 Financial Results on July 25, 2013

SOUTH SAN FRANCISCO, CA: ...

The Medicines Company Announces Positive Results for Solo II Trial of Oritavancin in the Treatment of Acute Bacterial Skin and Skin Structure Infections (ABSSSI)

PARSIPPANY, NJ: SOLO II Trial Meets All Protocol-Specified Endpoints Comparing Oritavancin, Given as One Single Dose, to Vancomycin Given Twice-Daily for 7-10 Days Intravenously; Combined SOLO I and SOLO II Findings ...

Biologix Hair Inc. Reports on Annual General Meeting Held June 28, 2013

TORONTO, ONTARIO: ...

Healthcare Corporation of America Names Experienced Corporate Attorney Mark Carlesimo as General Counsel

DENVILLE, NJ: ...

Rapid Micro Biosystems Secures $32.6 Million in Series B Financing

BEDFORD, MA: Longitude Capital and TPG Biotech Lead Investment With Participation From Existing Investors ...

Sirona Biochem Announces LOI for Collaboration with VitamFero

VANCOUVER, BRITISH COLUMBIA: ...

IsoRay Announces a New International Distributor in Australia and New Zealand

RICHLAND, WA: Aurora BioScience Pty Ltd Sees Exciting Opportunity in Offering IsoRay's Total Product Line ...